Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: Superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy

A. Santoro, G. Bonadonna, P. Valagussa, R. Zucali, S. Viviani, F. Villani, A. M. Pagnoni, V. Bonfante, R. Musumeci, F. Crippa

Research output: Contribution to journalArticle

289 Citations (Scopus)

Abstract

In an attempt to reduce some of the delayed sequelae associated with combined modality therapy in Hodgkin's disease, we randomly tested stages iiB, iiiA, and iiiB MOPP (mechlorethamine, vincristine, procarbazine, and prednisone) v ABVD (adriamycin, bleomycin, vinblastine, and dacarbazine). In 232 previously untreated patients, three cycles of either combination preceded and followed extensive irradiation. The complete remission rate was 80.7% following MOPP and 92.4% following ABVD (P

Original languageEnglish
Pages (from-to)27-37
Number of pages11
JournalJournal of Clinical Oncology
Volume5
Issue number1
Publication statusPublished - 1987

Fingerprint

Procarbazine
Mechlorethamine
Dacarbazine
Vinblastine
Bleomycin
Vincristine
Prednisone
Hodgkin Disease
Doxorubicin
Radiotherapy
Drug Therapy
Combined Modality Therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease : Superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. / Santoro, A.; Bonadonna, G.; Valagussa, P.; Zucali, R.; Viviani, S.; Villani, F.; Pagnoni, A. M.; Bonfante, V.; Musumeci, R.; Crippa, F.

In: Journal of Clinical Oncology, Vol. 5, No. 1, 1987, p. 27-37.

Research output: Contribution to journalArticle

Santoro, A. ; Bonadonna, G. ; Valagussa, P. ; Zucali, R. ; Viviani, S. ; Villani, F. ; Pagnoni, A. M. ; Bonfante, V. ; Musumeci, R. ; Crippa, F. / Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease : Superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. In: Journal of Clinical Oncology. 1987 ; Vol. 5, No. 1. pp. 27-37.
@article{905c8276acb846a6aa80f7a3e6e4b521,
title = "Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: Superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy",
abstract = "In an attempt to reduce some of the delayed sequelae associated with combined modality therapy in Hodgkin's disease, we randomly tested stages iiB, iiiA, and iiiB MOPP (mechlorethamine, vincristine, procarbazine, and prednisone) v ABVD (adriamycin, bleomycin, vinblastine, and dacarbazine). In 232 previously untreated patients, three cycles of either combination preceded and followed extensive irradiation. The complete remission rate was 80.7{\%} following MOPP and 92.4{\%} following ABVD (P",
author = "A. Santoro and G. Bonadonna and P. Valagussa and R. Zucali and S. Viviani and F. Villani and Pagnoni, {A. M.} and V. Bonfante and R. Musumeci and F. Crippa",
year = "1987",
language = "English",
volume = "5",
pages = "27--37",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "1",

}

TY - JOUR

T1 - Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease

T2 - Superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy

AU - Santoro, A.

AU - Bonadonna, G.

AU - Valagussa, P.

AU - Zucali, R.

AU - Viviani, S.

AU - Villani, F.

AU - Pagnoni, A. M.

AU - Bonfante, V.

AU - Musumeci, R.

AU - Crippa, F.

PY - 1987

Y1 - 1987

N2 - In an attempt to reduce some of the delayed sequelae associated with combined modality therapy in Hodgkin's disease, we randomly tested stages iiB, iiiA, and iiiB MOPP (mechlorethamine, vincristine, procarbazine, and prednisone) v ABVD (adriamycin, bleomycin, vinblastine, and dacarbazine). In 232 previously untreated patients, three cycles of either combination preceded and followed extensive irradiation. The complete remission rate was 80.7% following MOPP and 92.4% following ABVD (P

AB - In an attempt to reduce some of the delayed sequelae associated with combined modality therapy in Hodgkin's disease, we randomly tested stages iiB, iiiA, and iiiB MOPP (mechlorethamine, vincristine, procarbazine, and prednisone) v ABVD (adriamycin, bleomycin, vinblastine, and dacarbazine). In 232 previously untreated patients, three cycles of either combination preceded and followed extensive irradiation. The complete remission rate was 80.7% following MOPP and 92.4% following ABVD (P

UR - http://www.scopus.com/inward/record.url?scp=0023137367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023137367&partnerID=8YFLogxK

M3 - Article

C2 - 2433409

AN - SCOPUS:0023137367

VL - 5

SP - 27

EP - 37

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 1

ER -